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Inherited arrhythmia syndromes are a known, albeit rare, cause of sudden cardiac arrest which may
present with characteristic electrocardiogram changes in patients with structurally normal heart. There
are a variety of distinct arrhythmogenic syndromes that arise from mutations in voltage gated sodium
channels, resulting in either gain or loss of function. We describe a patient with a primary inherited
arrhythmia syndrome which presented as sudden cardiac arrest. Further workup revealed that her arrest
was due to a combination of Brugada syndrome and Long QT3 syndrome secondary to a deleterious
mutation of voltage-gated, sodium channel, type V alpha subunit (SCN5A Thr1709Met).
Copyright © 2016, Indian Heart Rhythm Society. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Inherited arrhythmia syndromes may cause sudden cardiac ar-
rest (SCA) in patients with a structurally normal heart. These
inherited arrhythmia syndromes usually present with character-
istic electrocardiogram (ECG) appearances. Mutations in the
voltage gated sodium channel can produce distinct arrhythmogenic
syndromes: Brugada syndrome (BrS), Long QT3 syndrome (LQT3)
and Progressive cardiac conduction disease. Mutations in BrS are
those of the loss in function of the sodium channel, whereas the
mutations in the LQT3 are those of the gain in the function of so-
dium channel. However, rarely a single gene mutation can present
with a phenotype overlap syndrome - both BrS and LQT3 in a same
patient. We present a case of primary inherited arrhythmia syn-
drome due to a deleterious mutation of voltage-gated, sodium
channel, type V alpha subunit (SCN5A) Thr1709Met leading to a
combination of BrS and LQT3.
1.1. Case presentation
A 57 year-old female collapsed in her kitchen and was subse-
quently found to be pulseless by family, who initiated bystander
CPR. EMS arrived after seven minutes and found her in shockablekshmanadoss).
Rhythm Society.
ociety. Production and hosting byrhythm. She received a total of six shocks and continued to have
recurrent ventricular tachyarrhythmia. She was treated with IV
lidocaine as a bolus. She had return of spontaneous circulation after
32 minutes of ACLS. Past medical history was signiﬁcant for hy-
pertension, depression and hypothyroidism. Medications included
citalopram 20 mgs, thyroxine 88mcg, lisinopril 10 mgs and hy-
drochlorothiazide 25 mgs daily. Family history was signiﬁcant for
SCA of her maternal uncle at the age of 40. She had no history of
recreational drug use. Vitals after initial resuscitation were as fol-
lows: BP 100/60 mmHg, Pulse 98/min. Physical examination was
unremarkable. Admission ECG showed sinus tachycardia, nonspe-
ciﬁc ST-T changes and QTc interval of 503 msec (Fig. 1A).
Blood chemistry showed potassium of 3.8 mEq/L and peak
troponin of 2.9 ng/ml. Echo revealed global left ventricular systolic
function with an estimated left ventricular ejection fraction of 30%
and normal right ventricular function. Normal coronary arteries
were found on cardiac catheterization. She was started on mild
induced therapeutic hypothermia (Temp of 32e33 C) protocol
after resuscitation. Her QTc prolonged to 630 msec with a long
isoelectric segment between the QRS and Twave during the peak of
hypothermia protocol when her baseline heart rate was 50 bpm
(Fig. 1B). After the completion of hypothermia protocol, her ECG
showed prominent coved ST segment elevation of 3mm in the right
precordial leads followed by T wave inversion (Fig. 2A). QRS dura-
tion in the right precordial leads was longer when compared to the
left precordial leads. QT dispersion was 60 msec (Fig. 2B). Her po-
tassium at that time was 4.1 mEq/L and magnesium was 1.9 mg/dl.Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
Fig. 1. A: Admission ECG, sinus tachycardia, nonspeciﬁc ST-T changes, QTc 503 msec. B: QTc interval 630 msec, long isoelectric segment between QRS and T wave.
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ﬁbrillation (VF) (Fig. 2C) requiring 18 deﬁbrillation shocks. Her core
body temperature was 36.2 C at that time. Her VF storm was
treated with isoproterenol infusion, followed by oral quinidine
400mg three times a day, with good control of her VF. After four
weeks, she was reevaluated in ofﬁce and noted to have petechial
rashes in the extremities and oral cavity. Complete blood count
showed platelet count of 5000/mL. Further evaluation was consis-
tent with drug induced idiopathic thrombocytopenic purpura. She
was treated with steroids and IV immunoglobulin with improve-
ment in platelet count. Her quinidine was discontinued and she
started having short runs of torsades de pointes (TDP) (Fig. 2D).
She was then started on disopyramide 150 mg q8h and up
titrated to 300 mg q8h, which was tolerated well with no recur-
rence of TDP. Her baseline ECG (Fig. 3) showed normal QTc interval
(437msecs) and type 2 Brugada pattern. Her follow up ECG showed
normal QTc interval. She later tested positive for class I deleterious
mutation of SCN5A Thr1709Met (Fig. 4), which has been associated
with prior cases of BrS. (http://www.transgenomic.com/product/
famillion-brs/; accessed on 11/4/2015). This is the ﬁrst reported
case of SCN5A Thr1709 missense mutation which presented as a
phenotypic overlap between BrS and LQT3.2. Discussion
We report a rare case of sudden cardiac arrest due to a combi-
nation of BrS and LQT3 syndrome secondary to deleteriousmutation of SCN5A Thr1709Met. Mutations in SCN5A have been
associated with at least three forms of primary electrical disorders,
namely LQTS3, BrS and progressive cardiac conduction defects [1].
Mutations in BrS are those of the loss in function of the sodium
channel during the phase 0 of the cardiac action potential, whereas
the mutations in the Long QT3 syndrome are those of the gain in
the function of sodium channel which is responsible for phase 2 of
the cardiac action potential. A single SCN5A insertion mutation
presenting with features of both BrS and LQT3 syndrome had been
reported [2]. This mutation produces an early sodium channel
closure, but augments the late sodium channel current due to a
slower recovery of the sodium channels from inactivation.
The cardiac Naþ channel a-subunit (SCN5A) is composed of four
homologous domains, DIeDIV (Fig. 4). In each domain, the S1eS4
segments serve as the voltage-sensing module, and the S5 and S6
segments and the reentrant loop between them serve as the pore-
formingmodulewhich is important for sodium inactivation. During
the Phase 1 of cardiac action potential, INa rapidly enters inside the
cell. Fast inactivation of the sodium channel is a critical process that
occurs withinmilliseconds of channel opening. The latch of this fast
inactivation gate (between S5 and S6 segments) is formed by three
key hydrophobic residues, isoleucine, phenylalanine, and methio-
nine, and an adjacent threonine (T). Any mutation involving these
channels could produce incomplete inactivation of INa, resulting in a
slow and constant entry of sodium during phase II of the action
potential and hence prolong QT interval [1].
Our patient initially displayed signiﬁcant QTc prolongation with
Fig. 2. A: Prominent ST elevation followed by T wave inversion in right precordial leads. B: QT dispersion in precordial leads. C: Torsades de pointes degenerating in to Ventricular
ﬁbrillation. D: Shorts runs of Torsades de pointes.
Fig. 3. Baseline pre -event ECG showing type 2 Brugada pattern and normal QTc interval.
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peak of hypothermia protocol. It is well known that Citalopram
could produce QTc prolongation in a dose dependent manner.
Recently, both the manufacturer of Citalopram and the US Food and
Drug Administration have warned about drug-induced QTc interval
prolongation and torsades de pointes when using citalopram in
doses >40 mg/day. Our patient was using Citalopram 20 mg daily,
and less likely to be the cause for QTc prolongation. It is possible
that incomplete inactivation of INa as a result of mutation in the
SCN5A gene likely contributed to abnormal repolarization at slow
rates [3]. Thus, bradycardia associated with hypothermia may have
precipitated QT-interval prolongation and abnormal T-wave
conﬁguration. LQT3 syndrome is an inherited cardiac arrhythmiathat may cause abrupt syncope, seizures and sudden death from
ventricular tachyarrhythmias, speciﬁcally TDP and VF. In LQT3 pa-
tients, a long isoelectric ST segment precedes a peaked T wave.
There is a persistent INa current during the plateau phase of the
action potential, secondary to incomplete inactivation of mutated
channels. This in turn leads to prolonged repolarization resulting in
the formation of early afterdepolarizations in phase III of the action
potential. These early afterdepolarizations trigger ventricular
ectopies, which initiate a short-long-short cycle, triggering torsade
de pointes in an underlying myocardial substrate of increased
dispersion of repolarization with partial recovery of action poten-
tial, especially in the middle layers (M cell) of myocardium [4].
There is also a marked transmyocardial dispersion due to a slower
Fig. 4. Missense mutant SCN5A Thr1709. Domain IeIV and Segments 1 to 6 of SCN5A. Thr1709 e Site of mutation between S5 and S6 in our patient.
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centration of slow activating, delayed rectifying IKs current.
Our patient also displayed ST elevation consistent with the
diagnosis of BrS after rewarming from hypothermia. BrS is diag-
nosed by an ECGwith STsegment elevation of equal to ormore than
2mm in at least one of the right precordial leads (V1, V2) positioned
in the 2nd, 3rd or 4th intercostal space, either occurring sponta-
neously or after the administration of intravenous sodium channel
blockers [5]. Patients may only intermittently display characteristic
ECG changes with otherwise normal ECG appearance. ECG abnor-
malities and arrhythmia induction in the SCN5A-linked forms of
BrS involve the imbalance of ionic currents during phase 1 repo-
larization. The deep phase 1 notch in the epicardial action potential,
particularly prominent in the right ventricle, renders it susceptible
to the effects of a reduction in the INaþ current. The reduction in INaþ
current establishes a steep voltage gradient across the right ven-
tricular wall (leading on to ST-elevation) due to short-circuiting of
the epicardial action potential with extreme shortening. The
imbalance of currents allows for reactivation of the right ventric-
ular epicardium by neighboring regions of myocardium, with
longer action potentials producing functional reentry, referred to as
phase 2 reentry [5]. QT intervals have been reported to be normal in
patients with BrS7. Patients who have QTc prolongation in the
setting of BrS should raise the suspicion of associated genetic
variation. Genetic testing could be of help in borderline cases or in
cases where a new mutation is suspected.
The objective of medical management of VF storm due to BrS is
to use drugs that inhibit the transient outward potassium current
(Ito) or increase the sodium and calcium currents. Isoproterenol
increases the L-type calcium current and proved to be useful for
treatment of electrical storm in the setting of BrS [5]. Quinidine,
which blocks Ito and Ikr currents, has been shown to prevent in-
duction of VF and suppress spontaneous ventricular arrhythmias
[5]. Use of disopyramide (due to Ito-suppressing effect) to treat VF
storm in BrS has also been reported [5]. The administration of cil-
ostazol may have a beneﬁcial effect in patients with the Brugada
syndrome by mediating an increase in calcium current and
reduction in I(to) due to an increase in heart rate [5]. Bepridil, a
class III drug with Ito blocking properties, is reported to be effective
in treating BrS patients with frequent VF recurrences, but the drug
is only available in Japan. In symptomatic patients with LQT3 syn-
drome where the torsade de pointes is either bradycardia or pause-
dependent, a pacemaker is used to avoid bradycardia and pauses.
Although beta-adrenergic blockers are used in the chronictreatment of LQT syndrome in general, these agents are used with
caution in patients with LQT3 syndrome, especially with resting
bradycardia since further reduction in heart rate by beta-adrenergic
blockers theoretically may provoke TDP. Ranolozine andMexiletine
may be used in patients with LQT3 syndrome due to their late INa
blocking effects.
In a patient with sudden cardiac arrest, certain clinical features
can point towards a SCN5A mutation: a long isoelectric ST segment
preceding a peaked T wave (LQT3); longer QTc interval in lead V2,
exercise induced ST segment elevation; long sinus pauses and
prolongation of P, PR interval or QRS widening with left axis de-
viation (PCCD) [1]. Therefore, evaluating the previous baseline ECGs
cannot be overemphasized.
3. Conclusion
The combination of ECG features suggesting LQT3 and BrS ECG
should make one think about the SCN5A mutation, which can
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